Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Neuftec Issues Patent Infringement Proceedings in the UK Against Oxonica

Abstract:
Neuftec Limited, the proprietor of the original nano-particulate cerium Oxide fuel
catalyst technology, today commenced patent infringement litigation in the UK
against Oxonica Energy Limited, a wholly owned subsidiary of Oxonica PLC .
The proceedings, issued in the High Court of Justice, allege infringement of
Neuftec's European patent.

Neuftec Issues Patent Infringement Proceedings in the UK Against Oxonica

ROSEAU, Commonwealth of Dominica | Posted on June 12th, 2008

The proceedings seek an injunction against Oxonica as well as damages in
relation to product already sold and delivery up or destruction of all
articles that would infringe Neuftec's European patent.


Oxonica and its legal advisors have previously made statements on at
least two occasions that they have no intention of dealing with products that
infringe any of Neuftec's issued patents. However, despite these statements
it is with regret that this is the second time, to the best of Neuftec's
knowledge, that Oxonica has infringed its granted patents.


The first infringement came in May 2007 when it came to Neuftec's
knowledge that Oxonica infringed the claims of Neuftec's Australian patent by
collecting a shipment of Envirox without the knowledge, consent or
authorization of Neuftec. This stock is estimated by Neuftec to have a resale
value of approximately US$1.8 million and cannot be used or sold without
Neuftec's permission. It has been stored in a warehouse in Australia since
March 2007.


The latest alleged infringement occurred when Oxonica shipped Envirox
formulations to Italy for use in Italian Government laboratory emission
testing.


Neuftec is continuing it's investigations with customers, distributors &
agents of Oxonica to determine the extent of the alleged infringement


Neuftec is represented in these proceedings by Watson, Farley & Williams
LLP & Mr. Mark Platts-Mills QC of 8 New Square, London.

####

About Neuftec Limited
Neuftec is a research & development company that owns patents in the fuel
catalyst technology sector used in the production of the first version of
EnviroxTM (2001-2007) that was manufactured by Advanced Nanotechnology
("ANO") of Australia under a manufacturing licence granted by Oxonica with
authorization from Neuftec.


On 29 February 2008, IP Australia issued a re-examination report in
respect of Neuftec's Australian patent. The patent had been issued in 2006
with 10 claims. In the re-examination report, IP Australia confirmed the
patentability of the 10 claims as originally granted in 2006 in
re-examination proceedings initiated by Oxonica.

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Legal

180 Degree Capital Corp. Issues Open Letter to the Board and Shareholders of Enzo Biochem, Inc. February 4th, 2021

Nanogate: Meeting of creditors on November 4, 2020 September 4th, 2020

GLOBALFOUNDRIES Files Patent Infringement Lawsuits Against TSMC In the U.S. and Germany: Injunctions seek to prevent unlawful importation of infringing Taiwanese semiconductors August 26th, 2019

SUNY CNSE and Albany Law School Partner to Create First-of-its-Kind Nanotechnology Education and Training Program November 5th, 2013

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

Energy

KAIST researchers introduce new and improved, next-generation perovskite solar cell​ November 8th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Groundbreaking precision in single-molecule optoelectronics August 16th, 2024

Development of zinc oxide nanopagoda array photoelectrode: photoelectrochemical water-splitting hydrogen production January 12th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project